RxDoctor Payments Data

Trisha Jenkins

Family · Saint Louis, MONPI 1740014208

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,376, more than ten times the $14 reported in 2023.

$1,417in general payments, 2019–2025

Across 71 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$230
  • AstraZeneca$124
  • Alkermes, Inc.$103
  • Otsuka America Pharmaceutical, Inc.$101
  • Novo Nordisk$76
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$75
  • plus $709 from 25 others

What the payments were for

  • Food & beverage$1,417100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,417 in reported general payments places this provider in the 70th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri →

Other family in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →